Comparison of the effect of two low-density lipoprotein receptor class mutations on coronary heart disease among French-Canadian patients heterozygous for familial hypercholesterolaemia

European Journal of Clinical Investigation

Volumn 27, Issue 5, 1997, Pages 366-373

  Vohl, M C ^a   Gaudet, D ^a,b   Moorjani, S ^a   Tremblay, G ^b   Perron, P ^b   Gagne C ^a,b   Lesiege D ^b   Bergeron, J ^a   Lupien, P J ^a   Despres J P ^a,c  

^a UNIVERSITÉ LAVAL   (Canada)

^b CHICOUTIMI HOSPITAL   (Canada)

^c LAVAL UNIVERSITY   (Canada)

Author keywords

Coronary artery disease; familial hypercholesterolaemia; LDL receptor gene mutations

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; TRIACYLGLYCEROL;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BODY MASS; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GENE LOCUS; GENE MUTATION; HETEROZYGOTE; HUMAN; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PREVALENCE; PRIORITY JOURNAL; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 8244235756     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1997.1250669.x     Document Type: Article

References (42)

1. Moorjani S, Roy M, Gagné C et al. Homozygous familial hypercholesterolemia among French Canadians in Québec province. Arteriosclerosis 1989;9:211-16.
2. Lehrman MA, Schneider WJ, Brown MS et al. The Lebanese allele at the LDL receptor locus: nonsense mutation produces truncated receptor that is retained in endoplasmic reticulum. J Biol Chem 1987;262:401-10.
3. Kotze MJ, Langenhoven E, Warnich L, du Plessis L, Retief E. The molecular basis and diagnosis of familial hypercholesterolemia in South African Afrikaners. Ann Hum Genet 1991;55:115-21.
4. Seftel HC, Baker SG, Jenkins T, Mendelsohn D. Prevalence of familial hypercholesterolemia in Johannesburg Jews. Am J Med Genet 1989;34:545-7.
5. Aalto-Setälä K, Koivisto UM, Miettinen TA et al. Prevalence and geographical distribution of major LDL receptor gene rearrangements in Finland. J Intern Med 1996;231:227-34.
6. Slimane MN, Pousse H, Maatoug F, Hammami M, Ben Farhat MH. Phenotypic expression of familial hypercholesterolaemia in central and southern Tunisia. Atherosclerosis 1993;104:153-8.
7. Leitersdorf E, Tobin EJ, Davignon J, Hobbs HH. Common low-density lipoprotein receptor mutations in the French Canadian population. J Clin Invest 1990;85:1014-23.
8. Bétard C, Kessling AM, Roy M, Chamberland A, Lussier-Cacan S, Davignon J. Molecular genetic evidence for a founder effect in familial hypercholesterolemia among French Canadians. Hum Genet 1992;82:529-39.
9. Gaudet D, Moorjani S, Gagné C et al. Premature coronary artery disease and high prevalence of monogenic traits for lipid disorders among French Canadians in north eastern region of Quebec province (abstract). Atherosclerosis 1996;109:131.
10. Gaudet D, Tremblay G, Perron P, Gagné C, Ouadahi Y, Moorjani S. L'hypercholestérolémie familial dans l'est du Québec: un problème de santé publique? L'expérience de la clinique des maladies lipidiques de Chicoutimi. L'union Médicale du Canada 1995;124: 54-60.
11. Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science 1986;232:34-47.
12. Moorjani S, Roy M, Torres AL et al. Mutations of low-density-lipoprotein-receptor gene, variation in plasma cholesterol, and expression of coronary heart disease in homozygous familial hypercholesterolaemia. Lancet 1993;341:1303-6.
13. Hobbs HH, Brown MS, Goldstein JL. Molecular genetics of the LDL receptor gene in familial hypecholesterolemia. Hum Mutat 1992;1:445-66.
14. Castelli WP, Garrison RJ, Wilson PWF, Abbot RD, Kalousdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framlingham study. JAMA 1986;256: 2835-8.
15. Stamler J, Wentworth D, Neaton JD. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356 222 primary screenees of the Multiple Risk Factor Intervention trial (MRFIT). JAMA 1986;256:2823-8.
16. Hamsten A. Apolipoproteins, dyslipoproteinaemia and premature coronary heart disease. Acta Med Scand 1988;223:389-403.
17. Bolibar I, Thompson SG, von Eckardstein A, Sandkamp M, Assmann G. Dose-response relationships of serum lipid measurements with the extent of coronary stenosis. Strong, independent and comprehensive. Arterioscler Thromb Vasc Biol 1995;15: 1035-42.
18. Gagné C, Moorjani S, Brun D, Toussaint M, Lupien P-J. Heterozygous familial hypercholesterolemia. Relationship between plasma lipids, lipoproteins, clinical manifestations and ischaemic heart disease in men and women. Atherosclerosis 1979;34:13-24.
19. Moorjani S, Gagné C, Lupien PJ, Brun D. Plasma triglycerides related decrease in high-density lipoprotein cholesterol and its association with myocardial infarction in heterozygous familial hypercholesterolemia. Metabolism 1986;35:311-16.
20. National Diabetes Data Group. Classification and diagnosis of diabetes and other categories of glucose intolerance. Diabetes 1979;28:1039-57.
21. The Airlie VA Consensus Conference. In: Lohman T, Roche A, Martorel R, eds. Standardization of anthropometric measurements. Champaign, IL: Human Kinetics Publishers;1988;39-80.
22. Burstein M, Samaille J. Sur un dosage rapide du cholestérol lié aux alpha et aux bêta lipoprotéines du sérum. Clin Chim Acta 1960;5:609.
23. McNamara JR, Schaefer EJ. Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions. Clin Chim Acta 1987;166:1-8.
24. 2+ precipitation procedure for quantitation of high-density lipoprotein cholesterol. Clin Chem 1982;28:1379-87.
25. Friedewald WT, Levy RI, Frederickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
26. Ma Y, Bétard C, Roy M, Davignon J, Kessling AM. Identification of a second French Canadian LDL receptor gene deletion and development of a rapid method to detect both deletions. Clin Genet 1989;36:219-28.
27. Vohl MC, Couture P, Moorjani S et al. Rapid restriction fragment analysis for screening four point mutations of low-density lipoprotein receptor gene in French Canadians. Hum Mutat 1995;6:243-6.
28. Couture P, Vohl MC, Gagné C et al. Identification of novel mutations in the low-density lipoprotein receptor gene causing familial hypercholesterolemia among French-Canadians. Hum Mutat 1997;(in press).
29. Ferrières J, Sing CF, Roy M, Davignon J, Lussier-Cacan S. Apolipoprotein E polymorphism and heterozygous familial hypercholesterolemia: sex-specific effect. Arterioscler Thromb 1994;14:1553-60.
30. Bétard C, Kessling AM, Roy M, Davignon J. Influence of genetic variability in the nondeletion LDL-receptor allele on phenotypic variation in French-Canadian familial hypercholesterolemia heterozygotes sharing a 'null' LDL-receptor gene defect. Atherosclerosis 1996;119:43-55.
31. Rosengren A, Wilhelmsen L, Eriksson E, Risberg B, Wedel H. Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men. Br Med J 1990;30:1248-51.
32. Schaefer EJ, Lamon Fava S, Jenner JL et al. Lipoprotein (a) levels and risk of coronary heart disease in men. The Lipid Research Clinics Coronary Primary Prevention Trial (see comments). JAMA 1994;271:999-1003.
33. Ridker PM, Hennekens CH, Stampfer MJ. A prospective study of lipoprotein (a) and the risk of myocardial infarction (see comments). JAMA 1993;270:2195-9.
34. Seed M, Hoppichler F, Reaveley D et al. Relation of serum lipoprotein (a) concentration and apolipoprotein (a) phenotype to coronary heart disease in patients with familial hypercholesterolemia. N Engl J Med 1990;322:1494-9.
35. Ferrieres J, Lambert J, Lussier-Cacan S, Davignon J. Coronary artery disease in heterozygous familial hypercholesterolemia patients with the same LDL receptor gene mutation. Circulation 1995;92:290-5.
36. Carmena R, Lussier-Cacan S, Roy M et al. Lp (a) levels and atherosclerotic vascular disease in a sample of patients with familial hypercholesterolemia sharing the same gene defect. Arterioscler Thromb Vasc Biol 1996;16:129-36.
37. Bowden JF, Pritchard PH, Hill JS, Frohlich JJ. Lp (a) concentration and apo (a) isoform size. Relation to the presence of coronary artery disease in familial hypercholesterolemia. Arterioscler Thromb 1994;14:1561-8.
38. Garcia MJ, McNamara PM, Gordon T, Kannell WB. Morbidity and mortality in diabetics in the Framlingham population. Diabetes 1996;23:105-11.
39. Kròlewski AS, Czyczyk A, Janeczko D, Kopczynski J. Mortality from cardiovascular disease among diabetics. Diabetologia 1977; 13:345-50.
40. Després JP, Moorjani S, Lupien PJ, Tremblay A, Nadeau A, Bouchard C. Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arteriosclerosis 1990;10:497-511.
41. Lapidus L, Bengtsson C, Larsson B, Pennert K, Rybo E, Sjöström L. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow-up of participants in the population study of Gothenberg, Sweden. Br Med J 1984;289:1261-3.
42. Larsson B, Svärdsudd K, Welin L, Wilhelmsen L, Björntorp P, Tibblin G. Abdominal adipose tissue distribution, obesity and risk factor of cardiovascular disease and death: 13 year follow-up of participants in the study of men born in 1913. Br Med J 1984; 288:1401-4.